Conagen Archives | Be Korea-savvy

Home / Posts tagged Conagen

Conagen Innovates Novel Natural-source Retinol for Cosmetic Formulations

Bedford, Mass., Aug. 22 (Korea Bizwire) – Conagen, the bioplatform innovator and biomanufacturer, has developed a first-of-its-kind, natural-sourced class of sustainable retinol derivative ingredients through precision fermentation. This achievement in new retinol active ingredients reshapes beauty and personal care applications. “Conagen is ready to commercialize these retinoid ingredients in 2024,” said VP of Flavors and Fragrances, Yisheng [...]

Conagen and Sumitomo Chemical Jointly Develop a New Era of Renewable Carbon Materials

Bedford, Mass., Aug. 1 (Korea Bizwire) – Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of sustainable production. Developing PHS [...]

Conagen Develops Debondable Adhesive for Textiles and Soft Materials from Natural Bioingredients

Bedford, Mass., July 11 (Korea Bizwire) — When more than 92 million tons of textile waste are landfilled annually, new solutions are needed to enable fabric reworking in manufacturing and recycling on a mass scale. Conagen, the biotechnology innovator, announced the development of a groundbreaking debondable textile adhesive made from high-performance materials sourced from sustainable and natural biomolecules. [...]

Conagen Starts First Commercial Production of Sustainable Tyrian Purple for Textile Dye

Bedford, Mass., Jan. 9 (Korea Bizwire) – Conagen announced the successful scale-up of its sustainable, cost-effective Tyrian purple, a historically coveted and expensive dye found in rare and limited sources in marine nature. Conagen is the world’s first and only biotechnology company commercializing a sustainable Tyrian purple by fermentation. As with any biologically-sourced textile dye, this color-fast compound [...]

Conagen Develops High-purity Non-GMO Sulforaphane by Bioconversion

Bedford, Mass., Nov. 29 (Korea Bizwire) — Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of [...]

Conagen’s Fermentation Platform Expands on Promising Novel Forms of Vitamin K2

Bedford, Mass., Oct. 31 (Korea Bizwire) — Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 – a high-purity all-trans menaquinone-7 (MK-7). This is the first molecule from a proprietary platform for producing novel, pure, long-chain menaquinone forms of the vitamin. The platform enables low-cost manufacturing and yields high-quality products, making it attractive to health brands. [...]

Conagen Unveils Commercial Production of High-purity Non-GMO Salidroside

Bedford, Mass., Sept. 27 (Korea Bizwire) – Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated with reducing inflammation, protecting against oxidative stress in cells, and providing relief from depression, fatigue, and stress. Salidroside has [...]

Conagen Commercializes Scalable Sweetness Enhancers from Nature

Bedford, Mass., July 8 (Korea Bizwire) – Conagen, the Massachusetts-based biotech firm, announced the commercialization of an expansive portfolio of natural sweetness enhancers for taste modification in sugar reduction solutions for food and beverages. The enhancers are made with precision fermentation, a technology that has led to the innovation of an extensive platform of phenolic antioxidants. Sweetness [...]

Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth

Bedford, Mass., May 31 (Korea Bizwire) — Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen’s dihydro resveratrol is made by bioconversion from p-coumaric acid (pCA), a natural preservative Conagen produced by precision fermentation. The same proprietary bioconversion technology used to make dihydro resveratrol can be [...]

Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies

Bedford, Mass., March 29 (Korea Bizwire) — The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax(TM) platform for the production of accessible low-cost and high-quality monoclonal antibodies, benefitting developing countries and patients globally. The high cost of monoclonal antibody (mAb) production makes blockbuster drugs expensive, limiting the markets in which these [...]